Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | TRPA1 | O75762 | 9/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | PORCN | Q9H237 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18166657 | 0.90 | MAPT (0.82) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL24767680 | 0.89 | MAPT (0.80) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL18166721 | 0.89 | MAPT (0.80) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL10114087 | 0.89 | MAPT (1.00) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL3266103 | 0.89 | MAPT (0.79) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL10113946 | 0.89 | MAPT (0.79) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL3248648 | 0.88 | MAPT (0.80) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL9933508 | 0.88 | MAPT (0.80) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL10114670 | 0.88 | MAPT (0.82) | MAPTSMN1; SMN2LMNATRPA1RXFP1 | |
| SCHEMBL18166618 | 0.87 | MAPT (0.79) | MAPTSMN1; SMN2LMNATRPA1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663295-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | ELI LILLY AND CO. (US) | 2020-06-10 | — | — | EP | disclosed |
| EP-3184527-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | Hydra Biosciences, Inc. (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-2170309-B1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | HYDRA BIOSCIENCES INC (US) | 2016-10-26 | — | — | EP | disclosed |
| WO-2010036821-A1 | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS | HYDRA BIOSCIENCES, INC. (US) | 2010-04-01 | — | — | WO | disclosed |